From September, Dr Baselga combines the scientific management of the Vall d’Hebron Institute of Oncology (VHIO) with his new appointment at the Hematology & Medical Oncology Division at the Cancer Center of the Massachusetts General Hospital at Harvard Medical School in Boston.
Related Posts
In The Lancet Oncology today: leading experts explore the potential impact of ´Brexit´ on cancer research and care across Europe
In a duo of commentaries plus an accompanying editorial published ahead of print today in The Lancet Oncology, experts explore…
27 Apr 2016
Spanish experts reflect about the role of women in Oncology
The first ESMO Women for Oncology Award was recently conferred to VHIO´s Enriqueta Felip during the European Cancer Congress, Vienna,…
29 Sep 2015
Hot off the press: VHIO´s 2014 Scientific Report now available
VHIO´s 2014 Scientific Report is now available either as a PDF (´light´version), or in its extended version online at: /scientific_reports/en_2014.php. Aside…
12 May 2015
Word Cancer Day and Declaration: "for a cancer free world"
World Cancer Day is the singular initiative under which UICC (Union for International Cancer Control), its members partners, supporters and…
25 Jan 2013
VHIO and the Weizmann Institute of Science: stimulating must-have conversation on Cellular Communication in Translational Research
• VHIO and the Weizmann Institute of Science provide a platform to exchange and debate latest research aimed at combating…
22 Jan 2015
The BBVA Foundation Tumor Biomarkers Research Program unites Massachusetts General Hospital Cancer Center and Vall d’Hebron Institute of Oncology in the search for personalized cancer therapies
The BBVA Foundation Tumor Biomarkers Research Program unites Massachusetts General Hospital Cancer Center and Vall d’Hebron Institute of Oncology in the search for personalized cancer therapies
16 Nov 2011
VHIO scientists and AICR Atlas trekking team to raise funds for cancer research: donate today
Comprised of AICR (now rebranded as Worldwide Cancer Research) donors, supporters, staff and AICR grant holders, some 15 individuals, including VHIO´s…
03 Mar 2014
Joint Vall d’Hebron University Hospital and VHIO project announced as Hinnovar Award finalist
The Hinnovar awards, organized by Novartis in collaboration with ESADE and the Spanish Society of Health Directives (SEDISA), aim to…
22 Nov 2013
Notch not only in cancer: VHIO´s María Abad describes the power of Notch inhibition in enhancing cardiac reprogramming
María Abad, who joined VHIO last summer from the Department of Molecular Biology, the University of Texas Southwestern Medical Center,…
07 Mar 2017
New Investigational Drug Targeting Difficult to Treat Breast Cancers to Undergo Pan-European Phase II Clinical Trials
Cancer researchers, oncologists and international pharmaceutical company join forces to test a new investigational drug for breast cancer Barcelona, 05…
05 Oct 2015
Vall d’Hebron opens the breast cancer center "Endavant i de Cara"
Queen Sofía and Councillor Marina Geli assist at the opening ceremony
07 Sep 2010
Gastrointestinal Cancers Symposium 2015: findings from a phase III study indicate a possible new treatment strategy for patients with advanced colorectal cancer
Results from an international phase III study of patients with advanced colorectal cancer, a disease which is especially difficult to…
16 Jan 2015
Global leader in oncology José Baselga awarded the ESMO Lifetime Achievement Award for his crucial role in drug development against breast cancer
Announced today by the European Society for Medical Oncology (ESMO), this year´s highly prestigious ESMO Lifetime Achievement Award honors the…
20 Jul 2017
Spanish retailer, El Corte Inglés, teams up with AECC to back breast cancer research of excellence
One of Spain´s major department store chains, El Corte Inglés, last week strengthened its collaboration with the Spanish Association against…
23 Mar 2016
Science comes to VHIO: 23 January 2012
Marking the second in the prestigious series of talks: VHIO Meet the Editors, Science´s Paula Kiberstis, Senior Editor, cancer research, will be joining us to deliver what promises to be a highly insightful presentation on Demystifying Science.
01 Dec 2011
